Home › Post-COVID Conditions (Long COVID) › Illinois › Chicago
Pag-aaral pangklinika para sa Post-COVID Conditions (Long COVID) sa Chicago, IL
Isang pag-aaral para sa Post-COVID Conditions (Long COVID) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Nagre-recruitPhase 3
- Rush University Medical Center ( Site 3748), Chicago
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Nagre-recruitPhase 3
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Nagre-recruitPhase 3
- Illinois Research Network (ILLInet), University of Illinois Chicago, Chicago
Dime La VerDAD: Verify, Debunk, and Disseminate
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University of Chicago, Chicago
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Nagre-recruitPhase 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Cognitive-Sensorimotor Function in Long-COVID
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Dysbiosis & Long COVID
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- The University of Chicago, Chicago
A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
- University of Chicago, Chicago
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
Nagre-recruitPhase 3
- University of Chicago Medical Center, Chicago
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Nagre-recruitPhase 3
- University of Illinois Health, Chicago
Convalescent Plasma as a Possible Treatment for COVID-19
Nagre-recruitPhase 2
- University of Illinois at Chicago, Chicago
Pag-aaral para sa Post-COVID Conditions (Long COVID) sa ibang lungsod
- New York City, NY15 pag-aaral
- Houston, TX13 pag-aaral
- Boston, MA13 pag-aaral
- Baltimore, MD12 pag-aaral
- Washington, DC10 pag-aaral
- San Francisco, CA8 pag-aaral
- Durham, NC8 pag-aaral
- Atlanta, GA8 pag-aaral
- San Diego, CA7 pag-aaral
- Los Angeles, CA6 pag-aaral
- Pittsburgh, PA6 pag-aaral
- Hialeah, FL6 pag-aaral
Iba pang pag-aaral sa Chicago
- Non-Small Cell Lung Cancer61 pag-aaral
- Kanser sa Suso59 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Metastatic Cancer45 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Baga41 pag-aaral
- Obesity41 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Colorectal Cancer34 pag-aaral
- Stroke34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Overweight29 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.